{
  "disease_name": "Homocystinuria due to cystathionine beta-synthase deficiency",
  "orpha_code": "394",
  "drugs": [
    {
      "name": "AMVERSIO",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/642395?name=394&mode=orpha&region=",
      "regulatory_id": "642395",
      "orpha_substance_code": "ORPHA:622",
      "details": [
        "AMVERSIO(Tradename                        - 05/05/2022)Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiencyORPHA:395 Homocystinuria due to methylene tetrahydrofolate reductase deficiencyORPHA:622 Homocystinuria without methylmalonic aciduria",
        "AMVERSIO(Tradename                        - 05/05/2022)",
        "(Tradename                        - 05/05/2022)",
        "Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiencyORPHA:395 Homocystinuria due to methylene tetrahydrofolate reductase deficiencyORPHA:622 Homocystinuria without methylmalonic aciduria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/642393?name=394&mode=orpha&region=&status=all",
          "text": "AMVERSIO",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/394",
          "text": "ORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/395",
          "text": "ORPHA:395 Homocystinuria due to methylene tetrahydrofolate reductase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/622",
          "text": "ORPHA:622 Homocystinuria without methylmalonic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/642395?name=394&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "CYSTADANE",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/131341?name=394&mode=orpha&region=",
      "regulatory_id": "131341",
      "orpha_substance_code": "ORPHA:622",
      "details": [
        "CYSTADANE(Tradename                        - 15/02/2007)Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiencyORPHA:395 Homocystinuria due to methylene tetrahydrofolate reductase deficiencyORPHA:26 Methylmalonic acidemia with homocystinuriaORPHA:622 Homocystinuria without methylmalonic aciduria",
        "CYSTADANE(Tradename                        - 15/02/2007)",
        "(Tradename                        - 15/02/2007)",
        "Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiencyORPHA:395 Homocystinuria due to methylene tetrahydrofolate reductase deficiencyORPHA:26 Methylmalonic acidemia with homocystinuriaORPHA:622 Homocystinuria without methylmalonic aciduria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/33514?name=394&mode=orpha&region=&status=all",
          "text": "CYSTADANE",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/394",
          "text": "ORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/395",
          "text": "ORPHA:395 Homocystinuria due to methylene tetrahydrofolate reductase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/26",
          "text": "ORPHA:26 Methylmalonic acidemia with homocystinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/622",
          "text": "ORPHA:622 Homocystinuria without methylmalonic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131341?name=394&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Poly(oxy-1,2-ethanediyl), alpha-(carboxymethyl)-omega-methoxy-, amide with cystathionine gamma-lyase (Pyridoxal 5'-phosphate cofactor) (synthetic engineered human), tetramer",
      "substance_url": "/en/drug/substance/604899?name=394&mode=orpha&region=&status=all",
      "substance_id": "604899",
      "regulatory_url": "/en/drug/regulatory/604900?name=394&mode=orpha&region=",
      "regulatory_id": "604900",
      "orpha_substance_code": "ORPHA:394",
      "details": [
        "Poly(oxy-1,2-ethanediyl), alpha-(carboxymethyl)-omega-methoxy-, amide with cystathionine gamma-lyase (Pyridoxal 5'-phosphate cofactor) (synthetic engineered human), tetramer(Medicinal product                        - 19/10/2020)Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
        "Poly(oxy-1,2-ethanediyl), alpha-(carboxymethyl)-omega-methoxy-, amide with cystathionine gamma-lyase (Pyridoxal 5'-phosphate cofactor) (synthetic engineered human), tetramer(Medicinal product                        - 19/10/2020)",
        "(Medicinal product                        - 19/10/2020)",
        "Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/604899?name=394&mode=orpha&region=&status=all",
          "text": "Poly(oxy-1,2-ethanediyl), alpha-(carboxymethyl)-omega-methoxy-, amide with cystathionine gamma-lyase (Pyridoxal 5'-phosphate cofactor) (synthetic engineered human), tetramer",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/394",
          "text": "ORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/604900?name=394&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "polyethylene glycol-modified human recombinant truncated cystathionine beta-synthase",
      "substance_url": "/en/drug/substance/480021?name=394&mode=orpha&region=&status=all",
      "substance_id": "480021",
      "regulatory_url": "/en/drug/regulatory/480022?name=394&mode=orpha&region=",
      "regulatory_id": "480022",
      "orpha_substance_code": "ORPHA:394",
      "details": [
        "polyethylene glycol-modified human recombinant truncated cystathionine beta-synthase(Medicinal product                        - 30/05/2016)Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
        "polyethylene glycol-modified human recombinant truncated cystathionine beta-synthase(Medicinal product                        - 30/05/2016)",
        "(Medicinal product                        - 30/05/2016)",
        "Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/480021?name=394&mode=orpha&region=&status=all",
          "text": "polyethylene glycol-modified human recombinant truncated cystathionine beta-synthase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/394",
          "text": "ORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/480022?name=394&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Betaine anhydrous",
      "substance_url": "/en/drug/substance/33515?name=394&mode=orpha&region=&status=all",
      "substance_id": "33515",
      "regulatory_url": "/en/drug/regulatory/133728?name=394&mode=orpha&region=",
      "regulatory_id": "133728",
      "orpha_substance_code": "ORPHA:394",
      "details": [
        "Betaine anhydrous(Medicinal product                        - 09/07/2001)Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
        "Betaine anhydrous(Medicinal product                        - 09/07/2001)",
        "(Medicinal product                        - 09/07/2001)",
        "Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/33515?name=394&mode=orpha&region=&status=all",
          "text": "Betaine anhydrous",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/394",
          "text": "ORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/133728?name=394&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "CYSTADANE",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/131109?name=394&mode=orpha&region=",
      "regulatory_id": "131109",
      "orpha_substance_code": "ORPHA:2170",
      "details": [
        "CYSTADANE(Tradename                        - 25/10/1996)Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiencyORPHA:395 Homocystinuria due to methylene tetrahydrofolate reductase deficiencyORPHA:26 Methylmalonic acidemia with homocystinuriaORPHA:2169 Methylcobalamin deficiency type cblEORPHA:2170 Methylcobalamin deficiency type cblG",
        "CYSTADANE(Tradename                        - 25/10/1996)",
        "(Tradename                        - 25/10/1996)",
        "Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiencyORPHA:395 Homocystinuria due to methylene tetrahydrofolate reductase deficiencyORPHA:26 Methylmalonic acidemia with homocystinuriaORPHA:2169 Methylcobalamin deficiency type cblEORPHA:2170 Methylcobalamin deficiency type cblG",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/33514?name=394&mode=orpha&region=&status=all",
          "text": "CYSTADANE",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/394",
          "text": "ORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/395",
          "text": "ORPHA:395 Homocystinuria due to methylene tetrahydrofolate reductase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/26",
          "text": "ORPHA:26 Methylmalonic acidemia with homocystinuria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2169",
          "text": "ORPHA:2169 Methylcobalamin deficiency type cblE",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/2170",
          "text": "ORPHA:2170 Methylcobalamin deficiency type cblG",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131109?name=394&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Modified human cystathionine beta synthase messenger ribonucleic acid encapsulated in a lipid nanoparticle",
      "substance_url": "/en/drug/substance/687206?name=394&mode=orpha&region=&status=all",
      "substance_id": "687206",
      "regulatory_url": "/en/drug/regulatory/687539?name=394&mode=orpha&region=",
      "regulatory_id": "687539",
      "orpha_substance_code": "ORPHA:622",
      "details": [
        "Modified human cystathionine beta synthase messenger ribonucleic acid encapsulated in a lipid nanoparticle(Medicinal product                        - 18/07/2024)Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiencyORPHA:395 Homocystinuria due to methylene tetrahydrofolate reductase deficiencyORPHA:622 Homocystinuria without methylmalonic aciduria",
        "Modified human cystathionine beta synthase messenger ribonucleic acid encapsulated in a lipid nanoparticle(Medicinal product                        - 18/07/2024)",
        "(Medicinal product                        - 18/07/2024)",
        "Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiencyORPHA:395 Homocystinuria due to methylene tetrahydrofolate reductase deficiencyORPHA:622 Homocystinuria without methylmalonic aciduria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/687206?name=394&mode=orpha&region=&status=all",
          "text": "Modified human cystathionine beta synthase messenger ribonucleic acid encapsulated in a lipid nanoparticle",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/394",
          "text": "ORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/395",
          "text": "ORPHA:395 Homocystinuria due to methylene tetrahydrofolate reductase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/622",
          "text": "ORPHA:622 Homocystinuria without methylmalonic aciduria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/687539?name=394&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Live biotherapeutic consisting of metP and metDC genes which are incorporated into the genome of a probiotic strain of E. coli Nissie 1917",
      "substance_url": "/en/drug/substance/636572?name=394&mode=orpha&region=&status=all",
      "substance_id": "636572",
      "regulatory_url": "/en/drug/regulatory/636576?name=394&mode=orpha&region=",
      "regulatory_id": "636576",
      "orpha_substance_code": "ORPHA:394",
      "details": [
        "Live biotherapeutic consisting of metP and metDC genes which are incorporated into the genome of a probiotic strain of E. coli Nissie 1917(Medicinal product                        - 22/11/2022)Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
        "Live biotherapeutic consisting of metP and metDC genes which are incorporated into the genome of a probiotic strain of E. coli Nissie 1917(Medicinal product                        - 22/11/2022)",
        "(Medicinal product                        - 22/11/2022)",
        "Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/636572?name=394&mode=orpha&region=&status=all",
          "text": "Live biotherapeutic consisting of metP and metDC genes which are incorporated into the genome of a probiotic strain of E. coli Nissie 1917",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/394",
          "text": "ORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/636576?name=394&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "A modified version of methionine gamma-lyase (MGL) enzyme from the bacterium Pseudomonas entomophila",
      "substance_url": "/en/drug/substance/643857?name=394&mode=orpha&region=&status=all",
      "substance_id": "643857",
      "regulatory_url": "/en/drug/regulatory/643858?name=394&mode=orpha&region=",
      "regulatory_id": "643858",
      "orpha_substance_code": "ORPHA:394",
      "details": [
        "A modified version of methionine gamma-lyase (MGL) enzyme from the bacterium Pseudomonas entomophila(Medicinal product                        - 18/01/2022)Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
        "A modified version of methionine gamma-lyase (MGL) enzyme from the bacterium Pseudomonas entomophila(Medicinal product                        - 18/01/2022)",
        "(Medicinal product                        - 18/01/2022)",
        "Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/643857?name=394&mode=orpha&region=&status=all",
          "text": "A modified version of methionine gamma-lyase (MGL) enzyme from the bacterium Pseudomonas entomophila",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/394",
          "text": "ORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/643858?name=394&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US",
        "EU"
      ]
    },
    {
      "name": "polyethylene glycol-modified human recombinant truncated cystathionine beta-synthase",
      "substance_url": "/en/drug/substance/480021?name=394&mode=orpha&region=&status=all",
      "substance_id": "480021",
      "regulatory_url": "/en/drug/regulatory/480026?name=394&mode=orpha&region=",
      "regulatory_id": "480026",
      "orpha_substance_code": "ORPHA:394",
      "details": [
        "polyethylene glycol-modified human recombinant truncated cystathionine beta-synthase(Medicinal product                        - 17/03/2015)Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
        "polyethylene glycol-modified human recombinant truncated cystathionine beta-synthase(Medicinal product                        - 17/03/2015)",
        "(Medicinal product                        - 17/03/2015)",
        "Disease(s) concernedORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/480021?name=394&mode=orpha&region=&status=all",
          "text": "polyethylene glycol-modified human recombinant truncated cystathionine beta-synthase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/394",
          "text": "ORPHA:394 Homocystinuria due to cystathionine beta-synthase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/480026?name=394&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:00:36.436548",
  "run_number": 1,
  "total_drugs_found": 10,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Homocystinuria+due+to+cystathionine+beta-synthase+deficiency&orphaCode=394&name=394&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Homocystinuria due to cystathionine beta-synthase deficiency",
    "orphaCode": "394",
    "name": "394",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}